| 1 |
Rudakova AV, Kharit SM, Rychkova SV, Lobzin YV. Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation. jour 2023;14:69-77. [DOI: 10.22625/2072-6732-2022-14-5-69-77] [Reference Citation Analysis]
|
| 2 |
Karakusevic A, Devaney P, Enstone A, Kanibir N, Hartwig S, Carias CDS. The burden of rotavirus-associated acute gastroenteritis in the elderly: assessment of the epidemiology in the context of universal childhood vaccination programs. Expert Rev Vaccines 2022;:1-12. [PMID: 35535677 DOI: 10.1080/14760584.2022.2066524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Hughes SL, Greer AL, Elliot AJ, McEwen SA, Young I, Papadopoulos A. Epidemiology of norovirus and viral gastroenteritis in Ontario, Canada, 2009-2014. Can Commun Dis Rep 2021;47:397-404. [PMID: 34737671 DOI: 10.14745/ccdr.v47i10a01] [Reference Citation Analysis]
|
| 4 |
Gower CM, Stowe J, Andrews NJ, Dunning J, Ramsay ME, Ladhani SN. Sustained declines in age group-specific rotavirus infection and acute gastroenteritis in vaccinated and unvaccinated individuals during the five years since Rotavirus vaccine introduction in England. Clin Infect Dis 2021:ciab460. [PMID: 34043765 DOI: 10.1093/cid/ciab460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Burnett E, Parashar UD, Tate JE. Global Impact of Rotavirus Vaccination on Diarrhea Hospitalizations and Deaths Among Children <5 Years Old: 2006-2019. J Infect Dis 2020;222:1731-9. [PMID: 32095831 DOI: 10.1093/infdis/jiaa081] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 6 |
Muchaal PK, Hurst M, Desai S. The impact of publicly funded rotavirus immunization programs on Canadian children. Can Commun Dis Rep 2021;47:97-104. [PMID: 33746618 DOI: 10.14745/ccdr.v47i02a02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Gates A, Gates M, Rahman S, Guitard S, MacGregor T, Pillay J, Ismail SJ, Tunis MC, Young K, Hardy K, Featherstone R, Hartling L. A systematic review of factors that influence the acceptability of vaccines among Canadians. Vaccine 2021;39:222-36. [PMID: 33257103 DOI: 10.1016/j.vaccine.2020.10.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 8 |
Fathima P, Jones MA, Moore HC, Blyth CC, Gibbs RA, Snelling TL. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis. J Epidemiol 2021;31:480-6. [PMID: 32801278 DOI: 10.2188/jea.JE20200066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Killikelly A, Shane A, Yeung MW, Tunis M, Bancej C, House A, Vaudry W, Moore D, Quach C. Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat. Can Commun Dis Rep 2020;46:62-8. [PMID: 32281988 DOI: 10.14745/ccdr.v46i04a02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Rafferty E, Guo X, McDonald B, Svenson LW, MacDonald SE. Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study. BMJ Open 2019;9:e031718. [PMID: 31678951 DOI: 10.1136/bmjopen-2019-031718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Kimura T, Okabe N. Passive surveillance of rotavirus gastroenteritis-associated hospitalization using nationwide administrative databases in Japan. Journal of Infection and Chemotherapy 2019;25:175-81. [DOI: 10.1016/j.jiac.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 12 |
Wilson SE, Rosella LC, Wang J, Renaud A, Le Saux N, Crowcroft NS, Desai S, Harris T, Bolotin S, Gubbay J, Deeks SL. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study. Vaccine 2019;37:2408-14. [PMID: 30765171 DOI: 10.1016/j.vaccine.2019.01.061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Doll MK, Quach C, Buckeridge DL. Evaluation of the Impact of a Rotavirus Vaccine Program on Pediatric Acute Gastroenteritis Hospitalizations: Estimating the Overall Effect Attributable to the Program as a Whole and as a Per-Unit Change in Rotavirus Vaccine Coverage. Am J Epidemiol 2018;187:2029-37. [PMID: 29757352 DOI: 10.1093/aje/kwy097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 14 |
Fu C, Dong Z, Shen J, Yang Z, Liao Y, Hu W, Pei S, Shaman J. Rotavirus Gastroenteritis Infection Among Children Vaccinated and Unvaccinated With Rotavirus Vaccine in Southern China: A Population-Based Assessment. JAMA Netw Open 2018;1:e181382. [PMID: 30646128 DOI: 10.1001/jamanetworkopen.2018.1382] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 15 |
Amrud K, Slinger R, Sant N, Desjardins M, Toye B. A comparison of the Allplex™ bacterial and viral assays to conventional methods for detection of gastroenteritis agents. BMC Res Notes 2018;11:514. [PMID: 30055653 DOI: 10.1186/s13104-018-3645-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 16 |
Isabel S, Higgins RR, Peci A, Isabel MR, Deeks SL, Gubbay JB. Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program. Vaccine 2018;36:2033-40. [PMID: 29526372 DOI: 10.1016/j.vaccine.2018.02.064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Wilson SE, Chung H, Schwartz KL, Guttmann A, Deeks SL, Kwong JC, Crowcroft NS, Wing L, Tu K. Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada. PLoS One 2018;13:e0192809. [PMID: 29444167 DOI: 10.1371/journal.pone.0192809] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 18 |
Rosettie KL, Vos T, Mokdad AH, Flaxman AD, Khalil I, Troeger C, Weaver MR. Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg 2018;98:1197-201. [PMID: 29436336 DOI: 10.4269/ajtmh.17-0705] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 19 |
Thomas MK, Murray R, Nesbitt A, Pollari F. The Incidence of Acute Gastrointestinal Illness in Canada, Foodbook Survey 2014-2015. Can J Infect Dis Med Microbiol 2017;2017:5956148. [PMID: 29410684 DOI: 10.1155/2017/5956148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 20 |
Le Saux N. Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons. Paediatrics & Child Health 2017;22:295-299. [DOI: 10.1093/pch/pxx071] [Reference Citation Analysis]
|
| 21 |
Le Saux N. Recommendations for the use of rotavirus vaccines in infants. Paediatr Child Health 2017;22:290-4. [PMID: 29483794 DOI: 10.1093/pch/pxx072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 22 |
Zelmer J. How We Will, Not Whether We Can: Improving Health and Healthcare. Healthc Policy 2017;12:8-11. [PMID: 28277200] [Reference Citation Analysis]
|
| 23 |
Murphy A. Rotavirus vaccine, breastfeeding, and other factors that could affect susceptibility to gastroenteritis in young children. Can J Public Health 2017;108:e101-e101. [DOI: 10.17269/cjph.108.6014] [Reference Citation Analysis]
|
| 24 |
Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother 2017;13:703-10. [PMID: 27835525 DOI: 10.1080/21645515.2016.1240846] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 25 |
Muhsen K, Kassem E, Rubenstein U, Goren S, Ephros M, Cohen D, Shulman LM. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel. Vaccine 2016;34:5916-22. [PMID: 27771186 DOI: 10.1016/j.vaccine.2016.10.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 26 |
Burnett E, Yen C, Tate JE, Parashar UD. Rotavirus vaccines: current global impact and future perspectives. Future Virol 2016;11:699-708. [PMID: 27840654 DOI: 10.2217/fvl-2016-0082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
